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DCs are immune accessory cells critical for both 
innate and adaptive responses against pathogens 
(Steinman, 2012). Multiple subtypes of DCs 
have been identified that have distinct functions 
and molecular characteristics (Shortman and 
Naik, 2007). The types of DCs that appear to be 
present in both human and mouse include plas-
macytoid DCs (pDCs), which generate type-1 
interferon, and antigen-presenting classical DCs 
(cDCs), both of which are present in lym-
phoid and nonlymphoid tissues. At steady-state, 
cDCs can be further divided into CD8+ and 
CD8 subsets, which possess differential ca-
pacities for promoting responses to pathogens 
as a result of differences in their ability to cross-
present antigens and secrete cytokines (den Haan 
et al., 2000; Hildner et al., 2008). Moreover, 
upon infection, additional subsets of cDCs can 
be induced from monocytes and share many of 
the distinguishing markers of homeostatic cDCs 
but may carry out distinct functions (Cheong 
et al., 2010).
Distinguishing these various DC subsets from 
closely related lineages such as monocytes and 
macrophages remains problematic. First, distinc-
tions are based on patterns and expression lev-
els of many surface markers rather than a single 
unique identifier. Second, expression levels for 
these markers may be altered by cellular activa-
tion through cytokines and innate sensing path-
ways or anatomical localization (Geissmann et al., 
2010; Hume, 2011). In analyzing the physio-
logical role of DCs, CD11c has frequently been 
used as a surrogate marker to identify the lineage. 
As such, the CD11c locus has been modified to 
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Distinguishing dendritic cells (DCs) from other cells of the mononuclear phagocyte system 
is complicated by the shared expression of cell surface markers such as CD11c. In this 
study, we identified Zbtb46 (BTBD4) as a transcription factor selectively expressed by 
classical DCs (cDCs) and their committed progenitors but not by plasmacytoid DCs (pDCs), 
monocytes, macrophages, or other lymphoid or myeloid lineages. Using homologous recom-
bination, we replaced the first coding exon of Zbtb46 with GFP to inactivate the locus 
while allowing detection of Zbtb46 expression. GFP expression in Zbtb46gfp/+ mice recapitu-
lated the cDC-specific expression of the native locus, being restricted to cDC precursors 
(pre-cDCs) and lymphoid organ– and tissue-resident cDCs. GFP+ pre-cDCs had restricted 
developmental potential, generating cDCs but not pDCs, monocytes, or macrophages. Outside 
the immune system, Zbtb46 was expressed in committed erythroid progenitors and endo-
thelial cell populations. Zbtb46 overexpression in bone marrow progenitor cells inhibited 
granulocyte potential and promoted cDC development, and although cDCs developed in 
Zbtb46gfp/gfp (Zbtb46 deficient) mice, they maintained expression of granulocyte colony-
stimulating factor and leukemia inhibitory factor receptors, which are normally down-
regulated in cDCs. Thus, Zbtb46 may help enforce cDC identity by restricting responsiveness 
to non-DC growth factors and may serve as a useful marker to identify rare cDC progenitors 
and distinguish between cDCs and other mononuclear phagocyte lineages.
© 2012 Satpathy et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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myeloid lineages. Furthermore, Zbtb46 expression identifies 
the earliest committed precursor of cDCs. Zbtb46 is not re-
quired for cDC development in vivo but regulates silencing 
of G-CSF and leukemia inhibitory factor receptors that 
normally occurs during cDC differentiation.
RESULTS
Zbtb46 is selectively expressed in cDCs  
and committed cDC progenitors
To identify transcription factors expressed in early cDC pro-
genitors but not in other myeloid precursors, we purified 
CMPs, GMPs, CDPs, and BM and splenic pre-cDCs (Fig. 1 A) 
and performed gene expression analysis (Fig. 1 B). Transcrip-
tion factors were compared for their induction in splenic 
pre-cDCs compared with BM CDPs and for their lineage 
specificity in cDCs compared with a broad panel of hemato-
poietic and nonhematopoietic cells (Fig. 1 B; Lattin et al., 2008). 
This method identified previously studied cDC genes, Batf3 
and Id2, as well as the novel factor Zbtb46. Zbtb46 was induced 
nearly 20-fold in splenic pre-cDCs relative to CDPs and was 
highly cDC specific across the tissue panel (Fig. 1 B).
Zbtb46 was expressed in both the CD8+ and CD4+ sub-
sets of cDCs but at very low levels in pDCs, monocytes, granu-
locytes, and T and B cells (Fig. 1 C). Zbtb46 is conserved as 
BTBD4 in humans, where it was also specifically expressed 
in both major subsets of cDCs but not pDCs, monocytes, 
granulocytes, or T, B, or NK cells (Fig. 1 D). In mouse, 
Zbtb46 was first expressed in the BM pre-cDC and increased 
during differentiation into mature cDC subsets (Fig. 1 E). In 
contrast, Irf8 was expressed in the earlier CMP and GMP 
stages, highly induced in the CDP, and maintained in the 
pre-cDC and subsequent CD8+ cDC and pDC. Expression 
of Batf3 was low in BM progenitors and was induced begin-
ning in the later splenic pre-cDC stage and maintained in 
mature cDCs (Fig. 1 E; Edelson et al., 2010).
Zbtb46-driven GFP expression identifies cDCs  
in lymphoid organs
Zbtb46 encodes a 601-aa member of the BTB-ZF family of 
transcriptional repressors (Kelly and Daniel, 2006) for which 
no studies have been reported. To examine its expression pat-
tern and function in vivo, we designed a targeting strategy 
to inactivate the locus while also allowing for detection of 
its expression. We inserted a GFP reporter cassette into exon 2 
beginning at the first coding methionine of Zbtb46, thus 
removing the native translational start site and completely 
eliminating exon 2, which encodes the Zbtb46 BTB domain 
(Fig. 2 A). Two ES cell clones harboring the correctly targeted 
Zbtb46gfp allele were obtained (Fig. 2 B) and used to generate 
germline-targeted mice on the pure 129SvEv genetic back-
ground (Fig. 2 C). Both of these correctly targeted clones 
were successfully transmitted through the germline, and 
progeny derived from each clone exhibited the same pheno-
type and patterns of GFP expression. Data in this study are 
exclusively from descendants of clone 102. Mice of genotypes 
Zbtb46gfp/+ and Zbtb46gfp/gfp are viable and are produced at 
express fluorescent reporters, Cre recombinase, or the diph-
theria toxin receptor (DTR) for the purpose of allowing 
tracking of DCs or to allow the inducible depletion of DCs 
for functional studies in vivo (Jung et al., 2002; Lindquist 
et al., 2004; Caton et al., 2007). However, the interpretation 
of studies using these reagents has been confounded by the 
expression of CD11c by other lineages (Probst et al., 2005; 
Murphy, 2011). For example, in CD11c-DTR mice, the de-
pletion of DCs by administration of diphtheria toxin A also 
leads to depletion of other cell types, including tissue-resident, 
marginal zone, and metallophilic macrophages, NK cells, and 
NKT cells, as well as some CD11c+ B and T cells (van Rijt 
et al., 2005; Bennett and Clausen, 2007; Hume, 2011). Other 
loci, including LysM, Csf1r, Cx3cr1, and CD11b, have been 
modified to express fluorescent proteins, but these are also 
expressed not only in DCs but in additional myeloid popula-
tions as well (Hume, 2011). No single marker has been iden-
tified to uniquely distinguish cDCs from other myeloid or 
lymphoid lineages, prompting the suggestion that identifica-
tion of bona-fide cDCs may require the simultaneous analysis 
of surface phenotype, cellular derivation, function, and ana-
tomical location (Geissmann et al., 2010).
DCs are derived from BM myeloid progenitors that 
undergo progressive lineage restriction. The common myeloid 
progenitor (CMP) generates the common DC progenitor 
(CDP), which has lost the ability to give rise to granulocytes 
and macrophages (derived from the downstream granulocyte 
macrophage precursor [GMP]) but still retains both pDC and 
cDC potential (Onai et al., 2007; Naik et al., 2007). The CDP 
appears to be the immediate precursor of both pre-pDCs 
(Cisse et al., 2008) and pre-cDCs (Naik et al., 2006; Liu et al., 
2009), which are restricted to their respective lineage but not 
yet fully mature. Terminal cDC development occurs in pe-
ripheral lymphoid and nonlymphoid organs after Flt3L (fms-
like tyrosine kinase 3 ligand)-dependent expansion (Waskow 
et al., 2008).
We previously suggested that accurately defining the cDC 
lineage might benefit from methods based on lineage-specific 
transcription factors induced during these early stages of com-
mitment (Satpathy et al., 2011). Several transcription factors 
have already been found to regulate DC development (Satpathy 
et al., 2011) but are not suitable for the purpose of specifically 
marking the lineage in vivo. For example, Irf8/ mice lack 
pDC as well as CD8+ cDC lineages but also have additional 
defects in other immune cell types (Schiavoni et al., 2002; 
Wang and Morse, 2009). Likewise, the transcription factor 
Batf3, which is required for the development of the CD8+ 
cDC lineage, is expressed in cDCs but also in other myeloid 
cells (Heng and Painter, 2008) and differentiated TH1 cells 
(Hildner et al., 2008).
In this study, we identify a member of the BTB-ZF (Broad 
complex, Tramtrack, Bric-à-brac, and Zinc finger) family (Kelly 
and Daniel, 2006), Zbtb46 (BTBD4), as specifically expressed 
in cDCs among immune lineages. By targeting the locus to 
express GFP, we are able to distinguish cDCs from all other 
lineages within the immune system, including closely related 
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Figure 1. Zbtb46 is expressed in BM pre-cDCs and cDCs in both mouse and human. (A) BM cells from WT mice were stained for expression of the 
indicated markers. Two-color histograms are shown for live cells pregated as indicated above the diagram. Numbers represent the percentage of cells 
within the indicated gate. Data are representative of five independent experiments with at least two mice each. (B) Sorted populations in A were analyzed 
by gene expression microarray as described in Materials and methods. Gene expression levels were determined for a list of all transcription factors using 
dChip software (Li and Wong, 2001a,b) for the splenic pre-cDC, BM CDP, CD8+ and CD4+ cDCs, and a broad panel of tissues (Lattin et al., 2008). For each 
transcription factor, the horizontal axis indicates the ratio of gene expression in the pre-cDC compared with the CDP, and the vertical axis indicates the 
ratio of the mean expression in CD8+ and CD4+ DCs compared with the mean expression in the tissue panel excluding DCs. Each dot indicates an indi-
vidual probe set. (C) Shown is the normalized expression value of Zbtb46 mRNA determined by quantitative RT-PCR for the indicated cell populations. 
Data represent three independently sorted replicates from three mice. (D) Shown is the expression value of BTBD4 mRNA in the indicated cells derived 
from Lindstedt et al. (2005) and Du et al. (2006). (E) Shown are the expression values for mouse Zbtb46, Irf8, and Batf3 mRNA transcripts in the indicated 
cell populations determined by expression microarray. Microarray analysis in B and E represents either two or three independently obtained arrays from 
progenitors sorted from three to five pooled WT mice. cDC arrays in E are derived from Robbins et al. (2008). (C–E) Bars represent the mean ± SEM.
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absence of Zbtb46 (Fig. 3 A). In spleen, GFP+ cells were 
overwhelmingly CD11c+MHCII+ and comprised both 
CD172+CD24 and CD172CD24+ populations (Fig. 3 B), 
indicating Zbtb46 expression in both major subsets of cDCs. 
In LNs, GFP was not only expressed by cells with high levels 
of CD11c, but also by migratory cDCs that expressed reduced 
levels of CD11c. Here, CD11chi cells expressed intermediate 
levels of MHCII, representing lymphoid-resident DCs, whereas 
CD11cint/lo cells expressed high levels of MHCII, represent-
ing migratory DCs (Fig. 3 B; Shortman and Naik, 2007). 
Again, GFP+ resident DCs in SLNs and MLNs contained both 
normal Mendelian frequencies from heterozygous breeding 
pairs. Zbtb46 transcripts were reduced in DCs isolated from 
Zbtb46gfp/gfp mice to background levels, indicating that this 
targeting strategy interrupted normal gene transcription as 
intended (Fig. 2 D).
We first analyzed Zbtb46 expression in lymphoid organs, 
including spleen, skin-draining LNs (SLNs), mesenteric LNs 
(MLNs), and thymus (Fig. 3 A). In CD45+ cells analyzed by 
FACS, GFP-expressing cells were present at equivalent fre-
quencies in both Zbtb46gfp/+ and Zbtb46gfp/gfp mice, indicating 
that no major populations of cells failed to develop in the 
Figure 2. Generation of the Zbtb46gfp locus. (A) The endogenous mouse Zbtb46 locus (top) contains five exons, with the first exon entirely noncoding 
and the second exon containing the methionine initiation codon and encoding the BTB domain of Zbtb46 (line). The Zbtb46 locus, the targeting vector, and 
mutant allele with retention of the neomycin (pGK-Neo) selection cassette are shown. Exons are displayed as boxes, with coding regions shaded. 
Double digestion of the germline locus with KpnI (K) and BamHI (B) yields a restriction fragment of 13.8 kB, which is detected by both the 5 probe and 
3 probe. Correctly targeted clones show an additional 7.3-kB band detected by the 5 probe and a 6.2-kB band detected by the 3 probe. Triangles indicate  
LoxP sequences. DTA, diphtheria toxin A; pA, polyadenylation signal; TK, thymidine kinase promoter. (B) Southern blot analysis of targeted clones.  
KpnI–BamHI double digests of clones 102, 136, and 137 were electrophoresed and hybridized with 5 probe as previously described (Kohyama et al., 2009).  
(C) Southern blot analysis of tail DNA. Tail biopsies of germline-transmitted descendents of clone 102 obtained from breeding of heterozygous Zbtb46gfp/+ 
mice were double digested with KpnI and BamHI, electrophoresed, and hybridized with 5 probe. Shown above the gel are the interpreted genotypes.  
(D) Splenic CD4+ cDCs and CD8+ cDCs were isolated from Zbtb46+/+ (WT) and Zbtb46gfp/gfp (KO) mice, and gene expression microarray analysis was per-
formed in comparison with WT CD4+ T cells. Shown is the expression value of the Zbtb46 probe set from the Affymetrix mouse Gene 1.0 array for the 
indicated cell types. Data are assembled from one to two replicate arrays obtained in one experiment.
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Fig. 8 D, bottom). This restricted GFP 
expression in cDCs but not pDCs 
was also observed in Flt3L-treated BM 
cultures (Fig. 3 D). Here, GFP expres-
sion was observed in both committed 
cDCs and pre-cDCs but not pDCs at 
both 6 and 9 d of differentiation.
Interestingly, Zbtb46 was also ex-
pressed in nonadherent CD11c+ cDCs 
generated in BM cultures treated with GM-CSF (Fig. 4 A; 
Sallusto and Lanzavecchia, 1994). Adherent cells either from 
GM-CSF–treated cultures, which represent macrophages and 
granulocytes, or from M-CSF–treated cultures, which repre-
sent macrophages, did not express Zbtb46 (Fig. 4 A). Purified 
monocytes cultured with GM-CSF induced the expression 
of Zbtb46 after 24 h (Fig. 4 B) and induced high levels of 
Zbtb46gfp after 4 d in culture (Fig. 4 C). Notably, after 4 d of 
treatment with GM-CSF alone, Zbtb46gfp was induced in 
75% of cells, whereas with the addition of both GM-CSF 
and IL-4, they became uniformly MHCII high and >95% GFP 
positive, indicating that IL-4 may enhance DC differentiation 
CD172+CD24 and CD172CD24+ populations (Fig. 3 B), 
indicating that Zbtb46 is expressed in all cDC subsets in 
peripheral lymphoid organs as well.
Notably, GFP expression was not detected in any other 
myeloid or lymphoid lineages (Fig. 3 C). In particular, pDCs 
were devoid of GFP expression in spleen, SLNs, and thymus, 
as were monocytes, granulocytes, and NK cells. Red pulp 
macrophages (RPMs) showed a low level of autofluorescence 
that did not represent authentic GFP expression, as similar 
levels of autofluorescence were observed in RPMs of Zbtb46+/+ 
(WT) mice (not depicted) and anti-GFP staining was not 
detected in RPMs by immunofluorescence microscopy (see 
Figure 3. Zbtb46gfp specifically identi-
fies cDCs in the mouse. Cells from 
Zbtb46+/+, Zbtb46gfp/+, and Zbtb46gfp/gfp were 
harvested from the spleen, SLNs, MLNs, and 
thymus as indicated and stained for CD11c, 
MHCII, CD172, CD24, and CD45. (A) Shown 
are two-color histograms for the indicated 
markers after gating for CD45 expression. 
Numbers represent the percentage of cells 
in the indicated gate. (B) Shown are two-
color histograms for the indicated markers 
derived from a GFP+ gate as indicated in  
A from Zbtb46gfp/gfp mice. (C) Shown are 
single-color histograms for GFP expression 
of cells from Zbtb46+/+ mice (WT) or cells 
from Zbtb46gfp/+ mice stained to identify 
cDCs (MHCIIhiCD11chi), resident cDCs  
(MHCIIintCD11chi), migratory cDCs  
(MHCIIhiCD11cint/lo), pDCs (CD317+B220+), 
RPMs (F4/80+ autofluorescent), monocytes  
(CD11bhiCD11cMHCIILy6G), granulo-
cytes (Ly6G+CD11b+), CD8+ T cells  
(CD8+CD11c), CD4+ T cells (CD4+CD11c), 
B cells (B220+MHCII+), NK cells (NKp46+),  
DP thymocytes (CD4+CD8+Lin), or DN thy-
mocytes (CD4CD8Lin). (D) BM cells from 
Zbtb46+/+ or Zbtb46gfp/+ mice were cultured 
with 100 ng/ml Flt3L for 6–9 d as indicated, 
harvested, and stained for CD11c, MHCII, 
and CD317. Gates identifying pDCs, cDCs, 
and precursors are indicated in two-color 
histograms for CD317 and MHCII expression 
on the left. Shown on the right are two-
color histograms for CD11c and GFP expres-
sion for pDCs, cDCs, and precursor cells.  
All data in this figure are representative of 
three to five independent experiments  
using at least two mice per group.
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such as lung (GeurtsvanKessel and Lambrecht, 2008), intestine 
(Manicassamy et al., 2010; Murphy, 2011), or kidney (Krüger 
et al., 2004). In the lung, cDCs and macrophages both ex-
press CD11c but differ in expression of CD103 and CD11b, 
with cDCs comprising CD103+CD11b, CD103+CD11b+, 
and CD103CD11b+ populations and macrophages residing 
within a CD103CD11blo/autofluorescent+ gate (Edelson 
et al., 2010). Consistent with this, we found that Zbtb46gfp  
was uniformly expressed in CD103+CD11b and CD103+ 
CD11b+ populations of cDCs and not expressed in CD11c+ 
CD103CD11blo/ macrophages (Fig. 5 A). Notably, the 
CD11c+CD103CD11b+ cells were heterogeneous for GFP 
expression, and although considered to represent cDCs 
(Edelson et al., 2010), our result suggests that this hetero-
geneous population likely includes GFP macrophages that 
resemble cDCs in marker expression but not transcriptional 
profile. This agrees with the suggestion of a recent study that 
peripheral CD11c+CD103CD11b+ cells contain macro-
phages as they show partial dependence on M-CSF (Ginhoux 
et al., 2009). Furthermore, Zbtb46 expression determined by 
microarray was high in both the CD103+CD11b and CD24+ 
CD11b+ cDC populations and low in lung macrophages 
(Fig. 5 B). The CD24CD11b+ lung cDCs expressed Zbtb46 
at an intermediate level, consistent with the notion of hetero-
geneity. Accordingly, analysis of lung tissue sections by im-
munofluorescence microscopy showed that only a subset of 
CD11b+ cells (Fig. 5 C) or CD11c+ cells (not depicted) were 
positive for expression of Zbtb46gfp. These GFP-positive cells 
were largely found to surround large vessels and conduct-
ing airways.
Another peripheral tissue in which the distinction of 
cDCs and macrophages is problematic is the lamina propria 
of the intestinal tract (Bogunovic et al., 2009; Varol 
et al., 2009), where both macrophages and DCs can express 
CD11c (Manicassamy et al., 2010; Murphy, 2011). In the 
lamina propria, we found that the majority of CD11c+ 
cells lacked expression of MHCII; these classically have 
been suggested to represent macrophages (Pabst and Bernhardt, 
2010). In agreement, we found that none of these CD11c+ 
MHCII cells expressed Zbtb46gfp (Fig. 5 D). Within 
CD11c+MHCII+ cells, Zbtb46gfp was uniformly expressed 
in the CD11b (CD103+) subset (Fig. 5 D), previously 
shown to be derived from CDPs (Bogunovic et al., 2009; 
Varol et al., 2009). However, among the CD11b+ subset of 
CD11c+MHCII+ cells, only half expressed Zbtb46gfp (Fig. 5 D). 
Again, this is consistent with previous suggestions that 
some CD11c+MHCII+CD11b+ cells in the lamina propria 
arise from monocytes and represent MHCII+ macrophages 
(Bogunovic et al., 2009; Varol et al., 2009). Consistently, 
Zbtb46 expression by microarray analysis was high in both 
of the CD103+ cDC subsets but low in lamina propria 
macrophages (Fig. 5 E).
In the kidney, Zbtb46 expression can similarly distin-
guish between cDCs and macrophages as in lamina pro-
pria and lung (Fig. 5 F). CD11c+ cells in the kidney have 
also been recognized to contain both cDCs and macrophages 
of monocytes. These results demonstrate that both Flt3L- and 
GM-CSF–dependent derivations of cDCs express Zbtb46, 
whereas macrophages and granulocytes do not.
Zbtb46gfp expression distinguishes cDCs  
from macrophages in peripheral tissues
A particular problem arises in using CD11c to distinguish 
cDCs from macrophages in peripheral nonlymphoid tissues 
Figure 4. GM-CSF–derived cDCs express Zbtb46gfp. (A) BM cells from 
C57BL/6 mice were treated with 20 ng/ml GM-CSF or M-CSF, and cultures 
were harvested on day 7 and divided into adherent and nonadherent frac-
tions. Nonadherent CD11c+ cDCs from the GM-CSF–treated cultures were 
purified by positive selection, and microarray analysis was performed on 
cDCs (GM-CSF CD11c+) and both adherent populations (Adh) for the indi-
cated cultures. Shown is the expression value of the Zbtb46 probe set.  
(B) BM monocytes were purified by negative selection using antibodies for 
Ly6G, B220, CD4, CD8, DX5, CD11c, Ter119, and CD117, resulting in a frac-
tion of cells that were >90% pure for expression of CD11b and Ly6C. Cells 
were cultured with 20 ng/ml GM-CSF for the indicated number of hours and 
harvested, and microarray analysis was performed. Shown is the expression 
value of the Zbtb46 probe set. Data in A and B are from one experimental 
replicate obtained from cells pooled from three mice. (C) Monocytes were puri-
fied from BM by cell sorting as CD11b+Ly6C+Ly6GCD11cMHCIISiglec-H  
cells and cultured in 20 ng/ml GM-CSF with or without 20 ng/ml IL-4 as 
indicated and analyzed after 4 d for expression of Zbtb46gfp and MHCII. Data 
are representative of one experiment in which each sample was performed 
in triplicate. Numbers represent the percentage of cells in the indicated gate.
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which are CD11c+MHCII+CD11b (Ginhoux et al., 2009), 
were uniformly positive for GFP expression. Finally, the 
CD11c+MHCII+CD11b+ cells, which have been suggested 
to represent CD11b+ cDCs, were heterogeneous for GFP 
expression, suggesting that some of these cells may represent 
an MHCII+ macrophage population as well.
(Krüger et al., 2004). As in the lamina propria, a large fraction 
of CD11c+MHCII cells coexpress CD11b and have been 
identified as macrophages (Krüger et al., 2004). We found 
that this population of macrophages was uniformly nega-
tive for GFP expression. In contrast, kidney cells that have 
been previously characterized to represent CD103+ cDCs, 
Figure 5. Zbtb46gfp distinguishes cDCs from macrophages in peripheral tissues. (A) Cells were harvested from perfused lungs of Zbtb46gfp/gfp mice 
and analyzed for expression of CD11c, MHCII, CD45, CD103, CD11b, GFP, and autofluorescence (centered on 700 nm). Shown (right) are two-color histo-
grams for GFP expression and autofluorescence for the indicated populations. Numbers represent the percentage of cells in the indicated gate. Data are 
representative of three independent experiments with three mice per group. (B) Shown are the mean expression values of Zbtb46 (±SEM) determined by 
microarray for the indicated cell populations derived from the ImmGen Database (Heng and Painter, 2008). Data are assembled from two to four replicate 
arrays. (C) Lung sections from Zbtb46gfp/+ BM chimeras were stained for CD11b and anti-GFP. Data are representative of five independent experiments. 
Bars, 200 µm. (D) Cells were harvested from small intestinal lamina propria of Zbtb46gfp/+ mice and analyzed for expression of CD11c, MHCII, CD45, 
CD103, CD11b, and GFP. Shown (right) are two-color histograms for CD11b and GFP expression for the indicated populations. Data are representative of 
three independent experiments with two mice each. (E) Shown are the mean expression values of Zbtb46 (±SEM) in the indicated cells derived from Heng 
and Painter (2008). Data are assembled from four to seven replicate arrays. (F) Cells harvested from the kidney from Zbtb46gfp/gfp mice were stained  
as in D. Data are representative of three independent experiments with two mice each.
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to represent a pDC-related lineage based on its E2-2 expres-
sion and immunoglobulin gene rearrangements but also re-
sembles cDCs by its high expression of CD11c and MHCII 
(Bar-On et al., 2010). LPS-induced CD206+ DCs arise from 
monocytes during inflammation, and so may represent mac-
rophages or DCs but were interpreted as DCs based on their 
Zbtb46 expression indicates the identity  
of unclassified myeloid cell types
Zbtb46 expression also clarifies the identity of several recently 
described myeloid cell types that have characteristics of both 
cDCs and other myeloid lineages. The recently described 
CX3CR1+CD8+ splenic population was initially thought 
Figure 6. Zbtb46gfp is expressed in CX3CR1+CD8+, LPS-induced, and CD169+ DCs. (A) Shown are single-color histograms of GFP expression 
from Zbtb46+/+ mice (WT) or Zbtb46gfp/+ mice and stained to identify cDCs (MHCIIhiCD11chi), CX3CR1+CD8+ DCs (CD8+MHCII+CD11chiDEC205), LPS-DCs 
(MHCIIhiCD11b+CD206+), CD11chiCD169+ cells, CD11cintCD169+ cells, or Tip-DCs (CD11cintCD11bhiLy6C+) according to the gating strategies shown in  
B–E. Data are representative of one to three independent experiments with at least three mice per group. (B) Splenocytes from Zbtb46+/+ and Zbtb46gfp/+ 
mice were stained for expression of the indicated markers. Cells within the indicated gate of the far left panel were analyzed for expression of DEC205 
and CD86 (middle left), and DEC205 and Zbtb46gfp (right panels) for either Zbtb46+/+ or Zbtb46gfp/+ mice. Data are representative of three independent 
experiments with three mice each. Numbers represent the percentage of cells in the indicated gate. (C) SLNs from Zbtb46+/+ and Zbtb46gfp/gfp mice treated 
i.v. with either PBS or 5 µg LPS were analyzed after 18 h for expression of the indicated markers for cells previously gated as indicated above the histo-
gram. Data are representative of two independent experiments involving three mice per group. (D) Cells from MLNs of Zbtb46gfp/+ mice were analyzed for 
expression of the indicated markers on cells previously gated as indicated above the histogram. Data are representative of three independent experiments 
with three mice per group. (E) Splenocytes from Zbtb46gfp/gfp mice infected with L. monocytogenes for 2 d were analyzed for expression of CD11b and 
CD11c (left) and gates established for monocytes, Tip-DCs, and cDCs. Cells within each gate were analyzed for expression of Ly6C and CD317.
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that this subset of CD169+CD11chi 
cells represents cDCs.
Finally, TNF/iNOS-producing 
DCs (Tip-DCs), which are of mono-
cyte origin and are induced after 
infection with Listeria monocytogenes 
(Serbina et al., 2003), were negative 
for expression of Zbtb46gfp (Fig. 6 A). 
This finding may indicate that Tip-
DCs are more highly related to a form of activated monocyte 
than to DCs, as recently suggested (Geissmann et al., 2010). 
Accordingly, these cells expressed Ly6C and CD317 similar to 
activated monocytes (Fig. 6 E). Of note, during L. monocyto-
genes infection or LPS-induced inflammation, Zbtb46gfp expres-
sion remained restricted to cDCs and loss of Zbtb46 did not 
affect the induction or maturation of cDCs (not depicted).
Zbtb46gfp is expressed in definitive erythroid precursors  
and endothelial cells
Above we observed that a small fraction of Zbtb46gfp-expressing 
cells were negative for CD11c and MHCII expression in 
lymphoid organs (Fig. 3 B). To determine the identity of 
these GFP-expressing cells, we first examined BM for indica-
tions of GFP expression in progenitor populations (Fig. 8 A). 
First, we noted that there were no changes in the frequency 
of progenitor populations between Zbtb46+/+ control and 
Zbtb46gfp/gfp mice (Fig. 8 A). Within these identified progeni-
tor populations, GFP was expressed only within the committed 
erythroid precursor populations: pre–CFU-erythroid (CFU-E) 
and CFU-E (Fig. 8, A and B; Pronk et al., 2007). How-
ever, unlike the persistent expression of GFP in mature DCs, 
GFP was not detectable in mature erythrocytes (Fig. 8 B). 
similarity to GM-CSF–derived DCs (Cheong et al., 2010). 
Notably, both of these types of cells were uniformly positive 
for Zbtb46gfp expression (Fig. 6, A–C), helping to exclude 
molecular heterogeneity within these populations and sup-
porting the interpretation that they represent cDC lineages.
In the past few years, a CD169+ population of cells located 
in the subcapsular region of LNs was interpreted to represent 
a novel subtype of macrophage that captures and preserves 
extracellular antigen for presentation to B cells (Junt et al., 
2007; Phan et al., 2009). Analysis of Zbtb46gfp/+ mice by FACS 
(Fig. 6, A and D) and immunofluorescence microscopy (Fig. 7, 
A and B) provides the first evidence that these cells may be 
molecularly heterogeneous. Approximately half of CD169+ 
subcapsular cells in both SLNs and MLNs were positive for 
Zbtb46gfp expression. In contrast, medullary macrophages, 
defined by their coexpression of CD169 and F4/80 (Phan et al., 
2009), were uniformly GFP negative (Fig. 7 C). Another 
recent study identified a separate subset of CD169+ cells that 
expresses high levels of CD11c and MHCII (Asano et al., 
2011), which by gene expression pattern resemble CD8+ 
cDCs (Heng and Painter, 2008) rather than macrophages. We 
found that this population of cells was uniformly positive for 
Zbtb46gfp expression (Fig. 6 D), favoring the interpretation 
Figure 7. Zbtb46gfp is expressed in a 
subset of CD169+ subcapsular cells but 
not in medullary macrophages. (A) SLN 
sections from Zbtb46gfp/+ → WT BM chimeras 
were analyzed by fluorescence microscopy 
for expression of B220, CD169, and GFP.  
(B) Areas B1 and B2 from A (right) are shown 
at higher magnification as indicated (first 
and second panels). Confocal images along 
three planes (x, y, and z; right) confirm GFP  
expression within CD169+ cells. (C) MLN 
sections from Zbtb46gfp/+ → WT BM chime-
ras were analyzed for expression of F4/80, 
CD169, and GFP. The area indicated as  
C1 (left) is shown at higher magnification 
(right) to demonstrate that medullary macro-
phages are negative for GFP expression  
(arrows). Immunofluorescence images are 
representative of three to four independent 
experiments with one or two mice each. Con-
focal images are representative of one inde-
pendent experiment in which three individual 
mice were analyzed. Bars: (A and C [left]) 
200 µm; (B [left and middle] and C [right]) 
50 µm; (B, right) 10 µm.
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Figure 8. Zbtb46 is expressed in definitive erythroid precursors and endothelial cells. (A) BM cells from Zbtb46+/+ (WT) or Zbtb46gfp/gfp (KO) mice 
were stained for expression of lineage markers B220, NKp461, and CD3 (Lin), Sca-1, CD16/32, CD41, CD105, CD117, CD135, and CD150 and analyzed using  
a FACSAria. Shown are two-color histograms for the indicated markers on cells previously gated for expression as indicated above the diagram. Numbers 
represent the percentage of cells within the indicated gate. The gates used to identify MkP, GMP, CMP, CDP, CFU-E, pre–CFU-E, pre-MegE, and pre-GM 
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populations for later GFP expression analysis are indicated. Data are representative of five independent experiments with at least two mice per group.  
(B) Shown are single-color histograms for GFP expression of cells stained in A for each indicated gate. (C) Shown are mean expression values of Zbtb46 
(±SEM) for each indicated cell population derived from Pronk et al. (2007). Data are assembled from two to four replicate arrays. (D) Spleen sections from 
Zbtb46gfp/+ (left) or Zbtb46gfp/+ → WT BM chimera (right) mice were stained for CD11c, B220, F4/80, and GFP. Arrows indicate GFP+CD11c endothelial 
cells. Data are representative of three independent experiments with one or two mice per group. Bars, 200 µm. (E) Splenocytes were stained for expression 
of CD11c, CD31, MADCAM-1, and Flk1. Shown are two-color histograms of cells from Zbtb46gfp/+ (left and middle) or a Zbtb46gfp/+ → WT BM chimera (right) 
for the indicated markers of cells previously gated as indicated above the diagram. Gates are labeled by cellular identity. Data are representative of three 
independent experiments with one or two mice each.
 
Consistently, among these populations, Zbtb46 messenger 
RNA (mRNA) was only observed in committed erythroid 
progenitors at 50% of the level of cDCs by microarray analy-
sis (Fig. 8 C). To determine whether expression of Zbtb46 in 
erythroid progenitors impacted gene expression, we purified 
pre-MegE, pre–CFU-E, and CFU-E populations from 
Zbtb46+/+, Zbtb46gfp/+, and Zbtb46gfp/gfp mice and performed 
microarray analysis. Notably, there was very little change 
in gene expression caused by the loss of Zbtb46 in these 
progenitors (Fig. S1 A).
We next examined Zbtb46gfp expression in the spleen 
using immunofluorescence (Fig. 8 D, left). As expected, GFP 
was observed in a subset of cells coexpressing CD11c, consistent 
with its expression by cDCs as determined by FACS. How-
ever, in addition, we observed that GFP was also expressed 
by cells associated with the vasculature of the splenic marginal 
zone and red pulp (Fig. 8 D), suggesting expression by endo-
thelium. To test this, we reexamined splenic stromal cells by 
FACS for GFP expression using markers to identify endothe-
lium and distinguish between these cells and DCs (Fig. 8 E). 
In spleen, the majority of GFP-expressing cells expressed 
CD11c, but 6% were negative for CD11c and were posi-
tive for CD31 expression. Of these cells, 24% expressed 
MADCAM-1 and Flk1, markers of endothelial cells associated 
with the marginal sinus (Zindl et al., 2009). Because endo-
thelial cells in adult mice are not of hematopoietic origin, we 
generated chimeras by transferring Zbtb46gfp/+ BM into lethally 
irradiated WT mice. In these chimeras, Zbtb46gfp expression 
remained specific but was no longer found in CD11cCD31+ 
endothelial cells either by FACS or by immunofluorescence 
(Fig. 8, D [right] and E). The use of radiation chimeras, 
either Zbtb46gfp/+ into WT or WT into Zbtb46gfp/+, could 
be used to isolate the GFP expression for functional stud-
ies of either DCs or endothelium, respectively. In summary, 
outside of its selective expression in cDCs within immune 
lineages, Zbtb46 is also expressed transiently by erythroid 
progenitors and constitutively by endothelial cells.
Zbtb46gfp identifies cDC-committed progenitors  
in BM and peripheral lymphoid organs
The lack of truly cDC-specific markers has confounded the 
purification of committed cDC progenitors away from cells 
capable of pDC development. The most successful purifications 
of a committed pre-cDC relied on CD11c and CD135, but 
these retained some pDC potential (Fig. 1 A; Liu et al., 2009), 
perhaps because of the expression of these markers on pre-pDCs 
as well. Furthermore, the in vivo expansion of pre-cDCs by 
Flt3L administration hinders their subsequent identifica-
tion because of the down-regulation of Flt3 (CD135) itself 
(Waskow et al., 2008). Finally, at the single cell level, a frac-
tion of cells identified as CDPs lacked pDC potential (Naik 
et al., 2007), suggesting the need for additional factors in de-
fining progenitors of DC lineages.
To ask whether Zbtb46 expression could distinguish 
between committed progenitors of cDCs and pDCs, we ana-
lyzed its expression in BM DC progenitors in Zbtb46+/+ and 
Zbtb46gfp/gfp mice. First, as in the spleen, mature BM pDCs 
did not express GFP in Zbtb46gfp/gfp mice, and mature BM 
MHCII+ cDCs were positive for GFP expression (Fig. 9 A). 
We examined GFP expression using levels of CD117 (c-kit) 
to distinguish CMPs (CD117hi), CDPs (CD117int), and the 
fraction containing pre-cDCs (CD117lo; Fig. 9 B, left). CMPs 
were completely negative for both GFP and Siglec-H, a marker 
expressed on pDCs (Zhang et al., 2006), as expected (Fig. 9 B, 
middle left). The current definition of CDPs uses LinSca-1 
IL-7RCD117intCD135+ gating (Naik et al., 2007; Onai 
et al., 2007), but it has been noted that a fraction of these cells 
are already committed to either pDC or cDC lineages (Naik 
et al., 2007). We noted both in Zbtb46+/+ and Zbtb46gfp/gfp 
mice that a small fraction of CDPs expressed Siglec-H. 
Importantly, these cells were heterogeneous for Zbtb46 expres-
sion. In Zbtb46gfp/gfp mice, GFP was expressed in approxi-
mately half of these Siglec-H+ CDPs (Fig. 9 B, middle right). 
In the CD117loCD135+ fraction containing pre-cDCs, a 
greater number of cells expressed Siglec-H, and again approx-
imately half expressed GFP (Fig. 9 B, right). This population 
of Siglec-H+Zbtb46+ cells could also be observed in peripheral 
lymphoid organs (Fig. 9 C).
We wondered whether GFP expression would mark defin-
itive commitment to the cDC lineage independent of Siglec-H 
expression. For this, we sorted the CD117lo cells into popula-
tions that were either Siglec-H+ Zbtb46gfp-negative or Siglec-H+  
Zbtb46gfp-positive and compared them with CDPs for their 
ability to generate pDCs and cDCs after in vitro culture with 
Flt3L (Fig. 9 D). Although CDPs and Siglec-H+ Zbtb46gfp-
negative cells could generate both cDCs and pDCs, the 
Siglec-H+ Zbtb46gfp-positive cells were able to generate only 
cDCs but not pDCs (Fig. 9 D). This indicates that expression of 
Zbtb46 identifies a committed progenitor of the cDC lineage. 
Furthermore, this commitment step does not require a functional 
Zbtb46 protein because cDCs developed from both Zbtb46+/+ 
and Zbtb46gfp/gfp progenitors. It will be interesting to determine 
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Figure 9. Zbtb46 expression identifies committed pre-cDCs in BM and peripheral lymphoid tissues. (A) BM from Zbtb46+/+ (WT) and Zbtb46gfp/gfp 
(KO) mice was stained for expression of Siglec-H, CD317, B220, CD11c, and MHCII. Shown are two-color histograms for Siglec-H and GFP expression for 
cells previously gated for positive expression of B220, CD317, and Siglec-H (pDC) or for positive expression of CD11c and MHCII (cDC) as indicated above 
the diagram. Numbers represent the percentage of cells within the indicated gate. Data are representative of three independent experiments with three 
mice each. (B) BM cells from Zbtb46+/+ (WT) and Zbtb46gfp/gfp (KO) mice were stained for expression of B220 and NKp46 (Lin), Sca-1, CD105, MHCII, CD117, 
CD135, CD11c, and Siglec-H. Shown are two-color histograms for expression of the indicated markers for cells previously gated as indicated above the 
diagram. Data are representative of five independent experiments with two mice each. (C) Splenocytes, SLNs, and MLNs from Zbtb46+/+ (WT) and Zbtb46gfp/gfp 
(KO) mice were analyzed for expression of CD11c, MHCII, B220, Siglec-H, and GFP. Shown are histograms depicting Siglec-H and GFP expression for cells 
previously gated as indicated above the diagram. Data are representative of two independent experiments with one or two mice each. (D) BM cells from 
Zbtb46gfp/gfp mice were sorted into populations of LinSca-1CD105CD117intCD135+MHCII (CDP; left), LinSca-1CD105MHCIICD117loCD135+ 
Siglec-H+GFP (Siglec-H+GFP; middle), or LinSca-1CD105MHCIICD117loCD135+Siglec-H+ and GFP+ (Siglec-H+GFP+; right) as indicated above the 
diagram. Cells were cultured in 100 ng/ml Flt3L for 4 d and analyzed by FACS for expression of Siglec-H, GFP, and MHCII. Data are representative of three 
independent experiments with two to three mice each.
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whether the divergence of pDCs and cDCs takes place at the 
Siglec-H+Zbtb46 stage of CDP development.
Zbtb46 represses alternate myeloid potential  
in BM progenitor cells
Because Zbtb46 expression first became apparent at the pre-
cDC stage, we wondered whether it might act in regulating 
lineage restriction of cDCs. We expressed Zbtb46 by retrovirus 
in BM cells and examined its effect on myeloid differentia-
tion in a system using a mixture of factors supporting both 
DC and alternate myeloid lineage development (Fig. 10, 
A and B). Although infection of progenitors with control 
retroviruses supported development of both granulocytes 
and cDCs in this setting, expression of Zbtb46 led to a 10-fold 
reduction in the growth of granulocytes and an enhanced 
outgrowth of cDCs. Notably, this effect was even evident 
Figure 10. Zbtb46 inhibits granulocyte  
potential, enhances cDC development, and 
regulates expression of non-DC growth factor 
receptors. (A) GFP-RV (Empty-RV; Ranganath et al., 
1998) or a retrovirus encoding mouse Zbtb46 
(Zbtb46-RV) was used to infect BM cells and cul-
tured with growth factors as described in Materi-
als and methods. On day 5, cells were harvested 
and analyzed for expression of Gr1, MHCII, and 
GFP. Shown are two-color histograms for the 
retroviral constructs indicated above the diagram 
for the indicated markers for cells gated on posi-
tive expression of GFP (GFP+). Numbers represent 
the percentage of cells in the indicated gates. 
Data are representative of three independent 
experiments using at least two mice per group. 
(B) Replicates from two experiments (each experi-
ment is uniquely colored) described in A are 
shown. Numbers represent the percentage of cells 
on day 5 that are present within the gates for 
cDCs or granulocytes (Gr1+) as indicated below 
the diagram. Bars represent the mean ± SEM.  
(C) BM from WT or BXH2 recombinant inbred 
mice (Tailor et al., 2008) was infected with GFP-RV,  
a retrovirus encoding full-length mouse Irf8 (Irf8-RV) 
or Zbtb46-RV as described in A and analyzed on 
day 5 for expression of CD11c and MHCII. Similar 
diminishment of cDC development was seen with 
Irf8/ BM, which was similarly restored by 
Zbtb46-RV (not depicted). Data are representative 
of two independent experiments with two mice 
per group. (D) GFP-RV vector (Empty-RV) or retro-
viruses expressing full-length Zbtb46 (Zbtb46-RV) 
or a truncated Zbtb46 in which the region of 
cDNA encoding the C-terminal zinc finger do-
mains (amino acids 404–601) were removed  
(dZF-Zbtb46-RV) and were used to infect BM 
progenitors as described in A, and cells were 
transferred into sublethally irradiated CD45.1 
recipients. After 14 d, splenocytes were harvested 
from recipient mice, and CD45.2+GFP+ cells were 
analyzed for expression of CD11c, B220, and  
MHCII. Shown are the percentage of cells within 
the B220CD11c+ gate for cells previously gated 
as CD45.2+GFP+ for the indicated retroviral  
construct. Data are representative of three  
independent experiments with one mouse per 
group. (E) Sorted steady-state splenic CD172+CD4+ 
cDCs from Zbtb46+/+ (WT) and Zbtb46gfp/gfp  
(KO) mice were purified, and gene expression microarrays were performed. Genes that are increased in the WT sample relative to the Zbtb46gfp/gfp (KO) 
sample (left) are listed with the associated fold induction. Genes that are increased in Zbtb46gfp/gfp (KO) mice relative to WT are listed with their fold induction 
(right). (F) Fold changes of the indicated genes derived from E are shown for their expression in WT compared with Zbtb46gfp/gfp (KO) mice.
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because the former would likely cause the loss of some cDC 
populations not depleted by the latter.
Besides cDCs in lymphoid and peripheral tissues, several 
unconventional myeloid subsets have been described whose 
precise origin and identity have been unclear. In these cell 
types, examination of Zbtb46 expression seems to aid in their 
classification into either cDC or macrophage lineages. For 
example, Tip-DCs were originally described as a type of 
induced inflammatory DC lineage (Serbina et al., 2003) but 
recently were suggested to more closely resemble human M1 
macrophages (Geissmann et al., 2010). The lack of Zbtb46 
expression in Tip-DCs may support this latter interpretation. 
In addition, subcapsular macrophages expressing CD169 
were considered to represent an F4/80-negative macrophage 
lineage (Junt et al., 2007; Phan et al., 2009). Our results sug-
gest that this population is heterogeneous with respect to 
Zbtb46 expression and could indicate that these cells may be 
more closely related to cDCs than previously thought.
Although current results indicate that Zbtb46 is dispens-
able for development of the recognized types of cDCs, our 
analysis has not yet examined the functional properties of 
these cells in settings of immune challenge. We may conclude 
that specification and commitment in vivo appears normal, 
but we have uncovered some evidence for subtle changes in 
gene expression in CD4+ cDCs. These findings will require 
further studies to clarify the functional consequences of such 
changes. Importantly, heterozygous Zbtb46gfp/+ mice or BM 
chimeras should benefit studies in which the identification 
of cDCs or committed pre-cDCs from monocytes and macro-
phages is necessary.
MATERIALS AND METHODS
Mice. Zbtb46gfp mice were maintained on the pure 129SvEv background by 
mating germline progeny from the EDJ22 ESC line with mice purchased 
from Taconic. Experiments were performed with sex-matched littermate 
mice at 6–10 wk of age. Irf8/ mice were obtained from the European 
Mutant Mouse Archive and maintained on the C57BL/6 background. 
BXH2/TyJ mice were purchased from the Jackson Laboratory and main-
tained on the C57BL/6 background. Mice were bred and maintained in our 
specific pathogen–free animal facility according to institutional guidelines 
and with protocols approved by the Animal Studies Committee of Washington 
University in St. Louis.
Generation of the Zbtb46gfp targeting construct. The Zbtb46gfp target-
ing construct was assembled with the Gateway recombination cloning 
system (Invitrogen). To construct pENTR-lox-GFP.Neo, a 1,017-bp PCR 
product containing eGFP followed by the SV40-pA terminator was ampli-
fied from gDNA of CX3CR1gfp/+ mice (Jung et al., 2000) using primers 
f666-pEGFP-N, 5-AATAGTCGACCGGTCGCCACCATGGT-3, and 
r1635-pEGFP-N1, 5-AATCTCGAGATTAACGCTTACAATTTACG-
CCTTAAGATAC-3, and cloned into pGEM-T Easy (Promega). The result-
ing plasmid was digested using SalI and XhoI, and the 1,004-bp eGFP-pA 
cassette was cloned into the SalI site 5 of the PGK–neor (phosphoglycerate 
kinase promoter–neomycin phosphotransferase) gene cassette of the pLNTK 
targeting vector (Gorman et al., 1996) to generate pLNTK-EGFP (8,313 bp). 
Finally, the 2,825-bp eGFP-PGK–neor cassette from pLNTK-EGFP was 
released using SalI and XhoI and ligated bluntly into the 2,554-bp back-
bone of NotI-digested pENTR-lox-Puro (Iiizumi et al., 2006). To construct 
pENTR-Zbtb46-5HA, the 5 homology arm was amplified by PCR from 
129SvEv-EDJ22 ESC genomic DNA using the following oligonucleotides, 
when Zbtb46 was expressed in BM progenitors from Irf8 
mutant mice (either Irf8-deficient [not depicted] or BXH2 
recombinant inbred mice, harboring a point mutation in the 
Irf8 gene [Fig. 10 C; Tailor et al., 2008]), which normally do 
not support the development of cDCs. The effects of Zbtb46 
are specific because deletion of its zinc finger domains abro-
gated the enhancement of cDC development (Fig. 10 D).
Because Zbtb46 belongs to a family of transcriptional repres-
sors, some of which are known to participate in lineage fate 
decisions within the immune system (Wildt et al., 2007), we 
analyzed gene expression microarrays from WT or Zbtb46gfp/gfp 
CD4+ splenic cDCs to identify genes that may be induced or 
repressed by the loss of Zbtb46 (Fig. 10 E and Fig. S1 B). In 
these steady-state DCs, it appeared that Zbtb46 regulated 
relatively few target genes. Notably, among the few genes 
altered were the receptors for G-CSF (Csf3R) and leukemia 
inhibitory factor (Fig. 10 F), which were increased in their 
relative expression in Zbtb46-deficient CD4+ cDCs. These re-
sults suggest that Zbtb46 may enforce cDC lineage restriction 
by extinguishing the expression of alternate myeloid growth 
factor receptors.
DISCUSSION
The precise assignment of cellular identity can be hampered 
by the fact that many lineages share expression of common 
surface markers. This is particularly true for cDCs, which 
have overlapping expression of various markers in common 
with pDCs, monocytes, and macrophages. The hypothesis 
that transcription factors define distinct lineages prompted 
our efforts to generate a Zbtb46-knockin reporter to help 
distinguish between these closely related myeloid subsets. We 
find that within the immune system, Zbtb46 expression spe-
cifically identifies the cDC lineage, both in lymphoid and 
nonlymphoid tissues. Because Zbtb46 is also expressed in 
endothelial cells and transiently during erythroid differentia-
tion, studies such as intravital microscopy or lineage ablation 
using the Zbtb46 locus may benefit from the use of BM 
chimeras to eliminate effects of expression by non-DCs. In 
examining Zbtb46-deficient mice, it seems that cDCs, vas-
culature, and erythrocytes each develop without major 
abnormalities, suggesting that potential defects will reside in 
induced responses or that there is compensation by an un-
identified factor.
Our data indicate that Zbtb46 expression at the stage of 
the pre-DC is a marker for cells committed to the cDC lin-
eage that have lost potential for pDCs and other myeloid cells. 
This is a useful distinction because it has not been precisely 
clear at which point potential for pDC development is extin-
guished (Liu and Nussenzweig, 2010; Belz and Nutt, 2012). 
By combining Zbtb46gfp expression with analysis of other 
markers, we have determined that although Siglec-H is specific 
for pDCs in peripheral organs, BM progenitors expressing 
Siglec-H actually retain potential for cDC development. This 
result might explain discrepancies between two recent studies 
that attempted to deplete pDCs based either on Siglec-H–DTR 
(Takagi et al., 2011) or BDCA2-DTR (Swiecki et al., 2010) 
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(eBio440C), eFluor450 anti-CD31 (390), eFluor450 anti-Ter119 (Ter119), 
and PERCPCy5.5 anti-CD14 (Sa2-8). These reagents were purchased 
from Miltenyi Biotec: PE anti-CD205/DEC205 (NLDC-145) and APC 
anti-CD205/DEC205 (NLDC-145). APC anti-CD206 (MR5D3) was 
purchased from BioLegend. In general, all antibodies were used at a 1:200 
dilution. Anti-DEC205 was used at a 1:20 dilution. Cells were analyzed on 
FACSCanto II or FACSAria II flow cytometers (BD), and data were ana-
lyzed with FlowJo software (Tree Star). For immunofluorescence experi-
ments, the following antibodies were purchased from Invitrogen: rabbit 
polyclonal anti-GFP, Alexa Fluor 488 anti–rabbit IgG (A11034), streptavi-
din Alexa Fluor 555, and biotin anti-F4/80 (BM8); from BioLegend: Alexa 
Fluor 647 anti-CD11c (N418); from AbD Serotec: APC anti-CD169 
(3D6.112); and from eBioscience: biotin anti-B220 (RA3-6B2).
Progenitor isolation and cell culture. BM was harvested from femur, 
tibia, humerus, and pelvis. Bones were fragmented by mortar and pestle, 
and debris was removed by gradient centrifugation using Histopaque 
1119 (Sigma-Aldrich). Cells were passed through a 70-µm strainer, and 
red blood cells were lysed with ACK lysis buffer. Cells were counted on 
a Vi-CELL analyzer, and 5–10 × 106 were stained for analysis or entire 
BM stained for sorting. Gates used to define GMP, CMP, CDP, and 
pre-cDC are based on previous studies (Akashi et al., 2000; Onai et al., 
2007). CMPs were identified as Linc-kithiSca-1CD11cCD135+ 
CD16/32 and IL-7R. CDPs were identified as Linc-kitintSca-1CD135+ 
CD16/32 and IL-7R. GMPs were identified as LinCD135c-kithi 
Sca-1CD16/32+ and IL-7R. For cell purification by sorting we used a 
FACSAria. Cells were sorted into PBS supplemented with 0.5% BSA and 
2 mM EDTA. Cell purities of at least 95% were confirmed by postsort 
analysis. For Flt3L culture experiments, whole BM (2 × 106 cells/ml in 4 ml 
cIMDM for 6 or 9 d) or sorted cells (1–5 × 104 cells/200 µl cIMDM for 4 d) 
were cultured at 37°C in 100 ng/ml Flt3L (PeproTech). For GM-CSF and 
M-CSF culture experiments, whole BM (106 cells/ml in 4 ml cIMDM 
for 7 d) was cultured at 37°C in 20 ng/ml GM-CSF or M-CSF (Pepro 
Tech). For monocyte cultures, BM monocytes were identified as Ly6C+C
D11b+Ly6GCD11cMHCIISiglec-H, and 5 × 104 cells were sorted 
and cultured in 20 ng/ml GM-CSF with or without 20 ng/ml IL-4 for 
4 d (PeproTech).
Expression microarray analysis. Total RNA was isolated from cells 
using the RNAqueous-Micro kit (Invitrogen). For Mouse Genome 430 2.0 
arrays, RNA was amplified, labeled, fragmented, and hybridized using the 
3 IVT Express kit (Affymetrix). Data were normalized within experiments, 
and expression values were modeled using DNA-Chip analyzer (dChip) 
software (http://www.dChip.org; Li and Wong, 2001a). For Mouse Gene 
1.0 ST arrays, RNA was amplified with the WT Expression kit (Invitrogen) 
and labeled, fragmented, and hybridized with the WT Terminal Labeling 
and Hybridization kit (Affymetrix). Data were processed using RMA 
(robust multichip average) quantile normalization, and expression values 
were modeled using ArrayStar software (DNASTAR). All original micro-
array data have been deposited in GEO DataSets under accession 
no. GSE37030.
Quantitative RT-PCR. Gene expression analysis used cells isolated to 
>95% purity from WT 129SvEv spleens using a FACSAria II. RNA and 
cDNAs were prepared with RNeasy Micro kit (QIAGEN) and Superscript III 
reverse transcription (Invitrogen). Real-time PCR and a StepOnePlus Real-
Time PCR system (Applied Biosystems) were used according to the manu-
facturer’s instructions, with the Quantitation Standard-Curve method and 
HotStart-IT SYBR Green qPCR Master Mix (Affymetrix/USB). PCR 
conditions were 10 min at 95°C, followed by 40 two-step cycles consisting 
of 15 s at 95°C and 1 min at 60°C. Primers used for measurement of Zbtb46 
expression were as follows: Zbtb46 qPCR forward, 5-AGAGAGCACAT-
GAAGCGACA-3; Zbtb46 qPCR reverse, 5-CTGGCTGCAGACAT-
GAACAC-3; HPRT forward, 5-TCAGTCAACGGGGGACATAAA-3; 
and HPRT reverse, 5-GGGGCTGTACTGCTTAACCAG-3.
which contain attB4 and attB1 sites: 5-GGGGACAACTTTGTAT-
AGAAAAGTTGCTGGTTTGAATTAGGGTACTTGAAG-3 and 
5-GGGGACTGCTTTTTTGTACAAACTTGCTGGGAGTCTTG-
CTGCTGTGT-3. The attB4-attB1 PCR fragment was inserted into 
the pDONR (P4-P1R) plasmid (Invitrogen) by the BP recombination 
reaction generating pENTR-Zbtb46-5HA. To construct pENTR-Zbtb46-
3HA, the 3 homology arm was amplified by PCR from genomic DNA 
using the following oligonucleotides, which contain attB2 and attB3 sites: 
5-GGGGACAGCTTTCTTGTACAAAGTGGCGCTGACTCAG-
AAGAATGTC-3 and 5-GGGGACAACTTTGTATAATAAAGTT-
GAATAATTCTCTAATAGAATAT-3. The attB2-attB3 PCR fragment 
was inserted into pDONR(P2R-P3) plasmid (Invitrogen) by the BP re-
combination reaction generating pENTR-Zbtb46-3HA. LR recombi-
nation reaction was performed using pENTR-Zbtb46-5HA, pENTR-
Zbtb46-3HA, pENTR-lox-GFP.Neo, and pDEST DTA-MLS to generate 
the final targeting construct. The linearized vector was electroporated into 
EDJ22 embryonic stem cells (129SvEv background), and targeted clones 
were identified by Southern blot analysis with the 5 probe and confirmed 
with the 3 probe. Probes were amplified from genomic DNA using the 
following primers: Zbtb465P forward, 5-TTGTAGTCAGCTTCTCACTT-
GTC-3; Zbtb465P reverse, 5-CAGTATGTTCGTAGGTTTTGTGG-3; 
Zbtb463P forward, 5-CAATTAAGGAAAAGTTGAAG-3; and Zbtb463P 
reverse, 5-TTATCCATTGAGCTGTCTCT-3. Blastocyst injections were 
performed, and male chimeras were bred to female 129SvEv mice. Geno-
typing PCR was conducted to confirm germline transmission and further 
determine the genotype of progeny mice using the following primers: 
ScreenGFP reverse, 5-AACTTGTGGCCGTTTACGTC-3; Screen 5HA 
forward, 5-GACCTCATACCTCCTTAGCA-3; and Screen WT reverse, 
5-GGCGGAGTACATGAAGTCAA-3.
DC preparation. Lymphoid organ and nonlymphoid organ DCs were har-
vested and prepared as described previously (Edelson et al., 2010). In brief, 
spleens, MLNs, SLNs (inguinal), and kidneys were minced and digested in 
5 ml Iscove’s modified Dulbecco’s media + 10% FCS (cIMDM) with 250 µg/ml 
collagenase B (Roche) and 30 U/ml DNase I (Sigma-Aldrich) for 30 min at 
37°C with stirring. Cells were passed through a 70-µm strainer before red 
blood cells were lysed with ACK lysis buffer. Cells were counted on a Vi-CELL 
analyzer (Beckman Coulter), and 5–10 × 106 cells were used per antibody 
staining reaction. Lung cell suspensions were prepared after perfusion with 
10 ml Dulbecco’s PBS (DPBS) via injections into the right ventricle after 
transection of the lower aorta. Dissected and minced lungs were digested in 
5 ml cIMDM with 4 mg/ml collagenase D (Roche) for 1 h at 37°C with 
stirring. SI cell suspensions were prepared after removal of Peyer’s patches and 
fat. Intestines were opened longitudinally, washed of fecal contents, cut into 
0.5-cm pieces, and incubated in HBSS medium (Life Technologies) + 5% FBS + 
2 mM EDTA at 37°C for 20 min while shaking at 250 rpm. This process 
was repeated three times. The tissue suspensions were passed through a 100-µm 
filter, and the remaining tissue pieces were minced and incubated in HBSS 
medium + 5% FBS with collagenase B and DNaseI at 37°C for 30 min 
with shaking.
Antibodies and flow cytometry. Staining was performed at 4°C in the 
presence of Fc Block (clone 2.4G2; BD) in FACS buffer (DPBS + 0.5% BSA 
+ 2 mm EDTA). The following antibodies were purchased from BD: APC 
anti-CD4 (RM4-5), V450 anti-GR1 (RB6-8C5), PE-Cy7 anti-CD8 
(53–6.7), PE-Cy7 anti-CD24 (M1/69), and APC anti-CD172a/SIRP 
(P84). These were purchased from eBioscience: PE anti-NKp46 (29A1.4), 
PerCP-Cy5.5 anti-CD11b (M1/70), APC eFluor780 anti-CD11c (N418), 
PE anti-CD103 (2E7), APC anti-CD317/BST2 (eBio927), eFluor450 anti-
MHCII (I-A/I-E; M5/114.15.2), APC anti-CD45.2 (104), PerCP-Cy5.5 
anti-CD16/32 (93), PE anti-CD41 (eBioMWReg30), APC anti-Flk1 
(Avas12a1), APC anti-CD150 (mShad150), APC-eFluor780 anti-CD117 
(2B8), V500 anti-B220 (RA3-6B2), eFluor450 anti-CD105 (MJ7/18), PE anti-
CD135 (A2F10), biotin anti–MADCAM-1 (MECA-367), APC anti-F4/80 
(BM8), Alexa Fluor 700 anti–Sca-1 (D7), PerCP-eFluor710 anti–Siglec-H 
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